CNTA

Centessa Pharmaceuticals PLC - ADR

Are CNTA, WSR, GDOT Obtaining Fair Deals for their Shareholders? Are CNTA, WSR, GDOT Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, May 12, 2026 Insiders may stand to receive...

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CLBK, NFBK, AFBI, and CNTA $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CLBK, NFBK, AFBI, and CNTA PR Newswire NEW YORK, May 11, 2026 NEW YORK, May 11, 2026 /PRNewswire...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Centessa Pharmaceuticals plc (NasdaqGS: CNTA...

LLY jumps after crushing Q1 estimates and raising 2026 outlook, powered by surging Mounjaro and Zepbound sales and strong global demand.

Centessa Pharmaceuticals (NASDAQ:CNTA) Sets New 52-Week High - Still a Buy...

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Get Free Report) was the recipient of a significant drop in short interest in the month of April. As of April 15th, there was short interest totaling 3,468,688 shares, a drop of 47.5% from the March 31st total of 6,607,633 shares. Based on...

Eli Lilly made several multi-billion dollar acquisitions in 2026, with a strong focus on strengthening its oncology pipeline.

Lilly heads into Q1 earnings with GLP-1 drugs driving growth. However, pricing pressure, rising costs, and softer Foundayo launch trends cloud the near-term outlook.

B. Metzler seel. Sohn & Co. AG purchased a new position in Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 38,432 shares of the company's stock, valued at approximately $9...